MedTrace Logo

Identification of Neuromotor Signs in Preschool Children Suspected of Developmental Coordination Disorder

NCT06269796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 424

Last updated 2024-04-03

No results posted yet for this study

Summary

This prospective study aimed to detect neuromotor signs early in preschool children suspected of Developmental Coordination Disorder (DCD). Preschool children aged 3-5 years old from municipal kindergartens in Thessaloniki participated in this study. The Little DCDQ questionnaire and the BOT-2 (Bruininks-Oseretsky Test of Motor Proficiency) were used for assessment.

Conditions

  • Motor Skills Disorders
  • Child Development
  • Child, Preschool

Interventions

DIAGNOSTIC_TEST

Little Developmental Coordination Disorder Questionnaire (LDCDQ)

The Little Developmental Coordination Disorder Questionnaire (LDCDQ) is a parent questionnaire consisting of 15 items designed to screen for motor coordination difficulties in 3- and 4-year-old children. It comprises 15 items grouped into two distinct factors: gross motor skills and fine motor skills. A Likert scale is used, ranging from one to five, where one (1) indicates "Not at all like your child" and five (5) indicates "Very much like your child". The total of the 15 items is added up to obtain a total score of 75.

DIAGNOSTIC_TEST

Bruininks- Oseretsky Test of Motor Proficiency 2nd Edition (BOT-2)

The BOT-2 is standardized for children and adolescents aged 4 to 21 years and 11 months, and the full test takes 45 to 60 minutes to perform. The BOT-2 test was used to detect deviation from the norm and the likelihood of a diagnosis for DCD. The BOT-2 measures fine and gross motor proficiency, with subtests focusing on stability, mobility, strength, coordination, and object manipulation.

Sponsors & Collaborators

  • University of Thessaly

    lead OTHER

Principal Investigators

  • Ioannis Poulis, Prof · University of Thessaly

Eligibility

Min Age
3 Years
Max Age
5 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-07-31
Completion
2021-09-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06269796 on ClinicalTrials.gov